Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Dermatol ; 2024 Jun 24.
Artigo em Inglês | MEDLINE | ID: mdl-38924059

RESUMO

BACKGROUND: While electrochemotherapy (ECT) is increasingly utilized as a highly effective method in the treatment of tumors in the head and neck region, there is significantly less data available for eyelid-periocular skin tumors. Our group reported the first extensive case series of eyelid-periocular basal cell carcinoma (BCC) patients with short-term follow-up treatment with ECT. The present study aims to report our long-term results of eyelid-periocular BCC cases treated with ECT. METHODS: The treatments were performed according to the ESOPE (European Standard Operating Procedures on Electrochemotherapy) guidelines using the Cliniporator™ device. All patients received bleomycin-based ECT, administered intratumorally or intravenously. Tumor response was evaluated using the RECIST 1.1 criteria. RESULTS: The results of 19 patients treated with ECT are presented. Four patients had locally advanced primary tumors, while 15 patients had recurrent tumors. Bleomycin was administered intratumorally in four patients and intravenously in 15 patients. The overall response was 100%, while the complete response rate proved to be 95%. In three cases (15.8%), recurrence was observed during the mean follow-up period of 78.9 months. CONCLUSIONS: ECT can effectively treat locally advanced or recurrent BCC in the eyelid-periocular skin region. Excellent tumor control can be achieved with good functional and cosmetic results without systemic adverse events with long interval follow-up.

2.
Case Rep Ophthalmol ; 13(1): 210-214, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35611007

RESUMO

A 72-year-old male patient was referred to our outpatient clinic with a painful left eye protrusion accompanied by marked conjunctival chemosis and external ophthalmoplegia being progressed despite topical and oral antibiotic therapy. He developed ocular symptoms 9 days after receiving his second SARS-CoV-2 vaccine (VeroCell). Of note, in previous history, 2 weeks after the first dose of the COVID-19 vaccine, he also developed a life-threatening laryngeal oedema treated at an emergency care unit. MRI of the orbit excluded pansinusitis as possible origin of the orbital cellulitis, and repeated COVID-19 antigen and antibody PCR tests were negative during his hospitalization. On the next day after his admittance, parenteral dexamethasone 250 mg/die treatment was commenced resulting in a quick and complete resolution of the symptoms. Due to the facts regarding this case, such as the temporal coincidence and the lack of respective comorbidity, there might be a causative relationship between the vaccination and the presented orbital cellulitis. To the best of our knowledge, this is the first report on orbital cellulitis as a possible ocular adverse event following COVID-19 vaccination.

4.
Case Rep Ophthalmol Med ; 2019: 5830493, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31781447

RESUMO

Squamous cell papilloma (SCP) is generally a human papillomavirus (HPV) induced exophytic or endophytic proliferation on the surface of the skin, oral cavity, larynx, esophagus, cervix, vagina, and anal canal. The endophytic type SCP can cause differential diagnostic difficulties with keratoacanthoma, inverted follicular keratosis, and squamous cell carcinoma; however, these lesions are not associated with HPV infection. The authors present a female patient who noticed an extremely rapidly growing tumor destructing the left lower eyelid. The histological analysis of the biopsy sample revealed a virus-induced squamoproliferative lesion. The eyelid affected was completely removed, and the histological examination resulted in a HPV induced endophytic squamous cell papilloma. The tarsus and the conjunctiva were replaced by a chondromucosal graft harvested from the nasal septum, while the skin defect could be closed directly. Restoration of the eyelid function has been achieved with satisfying functional and cosmetic results.

5.
Sci Rep ; 9(1): 4285, 2019 03 12.
Artigo em Inglês | MEDLINE | ID: mdl-30862897

RESUMO

There is increasing evidence about the effectiveness of electrochemotherapy (ECT) in the treatment of basal cell carcinomas in the head and neck region, although its role in the management of eyelid-periocular skin tumors has to be clarified. The aim of the present study is to evaluate the results of ECT in the treatment of locally advanced primary and recurrent eyelid-periocular skin basal cell carcinomas. Twelve patients with basal cell carcinoma involving the eyelid-periocular skin region were treated with ECT. Three patients had locally advanced primary tumors, while 9 patients had recurrent tumors. All treatments were performed according to the ESOPE guidelines, using Cliniporator TM device. All patients received bleomycin based ECT. The route of administration was intratumoral in 3 patients and intravenous in 9 patients. Tumor response was evaluated using the RECIST 1.1. criteria. ECT resulted in complete response of the periocular skin tumors in all patients. Lower eyelid ectropion was developed in 3 patients which had to be corrected surgically. ECT can be used effectively in the treatment of locally advanced or recurrent basal cell carcinomas in the eyelid-periocular skin region. Excellent tumor control can be achieved with good functional and cosmetic results without systemic adverse events with short interval follow-up.


Assuntos
Carcinoma Basocelular/tratamento farmacológico , Carcinoma Basocelular/terapia , Eletroquimioterapia/métodos , Neoplasias Palpebrais/tratamento farmacológico , Neoplasias Palpebrais/terapia , Recidiva Local de Neoplasia/tratamento farmacológico , Recidiva Local de Neoplasia/terapia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antibióticos Antineoplásicos/uso terapêutico , Bleomicina/uso terapêutico , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/terapia , Resultado do Tratamento , Adulto Jovem
6.
Biointerphases ; 12(1): 011001, 2017 01 18.
Artigo em Inglês | MEDLINE | ID: mdl-28100054

RESUMO

Catheter associated urinary tract infections (CAUTI), caused by several strains of bacteria, are a common complication for catheterized patients. This may eventually lead to a blockage of the catheter due to the formation of a crystalline or amorphous biofilm. Inhibiting bacteria should result in a longer application time free of complaints. This issue has been investigated using an innovative type of silver-coated catheter with a semipermeable cap layer to prevent CAUTI. In this work, two different types of silver catheters were investigated, both of which were capped with poly(p-xylylene) (PPX-N) and exhibited different surface properties that completely changed their wetting conduct with water. The contact angle of conventionally deposited PPX-N is approximately 80°. After O2 plasma treatment, the contact angle drops to approximately 30°. These two systems, Ag/PPX-N and Ag/PPX-N-O2, were tested in synthetic urine at a body temperature of 37 °C. First, the optical density and the inhibition zones of both bacteria strains (Escherichia coli and Staphylococcus cohnii) were examined to confirm the antibacterial effect of these silver-coated catheters. Afterward, the efficacy of silver catheters with different treatments of biofilm formed by E. coli and S. cohnii were tested with crystal violet staining assays. To estimate the life cycles of silver/PPX-catheters, the eluted amount of silver was assessed at several time intervals by anodic stripping voltammetry. The silver catheter with hydrophilic PPX-N coating limited bacterial growth in synthetic urine and prevented biofilm formation. The authors attribute the enhanced bacteriostatic effect to increased silver ion release detected under these conditions. With this extensive preparatory analytic work, the authors studied the ability of the two different cap layers (without silver), PPX-N and oxygen plasma treated PPX-N, to control the growth of a crystalline biofilm by measuring the concentrations of the Ca2+ and Mg2+ ions after exposure of the catheters to saturated urine for 24 h. The higher concentrations of Ca2+ and Mg2+ in the precipitates on the PPX-N catheters indicates that the hydrophilic PPX-N coating is superior to the simple PPX-N coating, with regard to the formation of a crystalline biofilm. Moreover, hydrophilic PPX-N as a cap layer may promote wettability and increase silver ion release rate and thus reduce the adhesion of suspended crystals to the catheter. Reduced bacterial growth and reduced adhesion may help to prevent CAUTI.


Assuntos
Antibacterianos/farmacologia , Biofilmes/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Polímeros/farmacologia , Prata/farmacologia , Staphylococcus/efeitos dos fármacos , Cateteres Urinários/microbiologia , Xilenos/farmacologia , Materiais Revestidos Biocompatíveis/química , Escherichia coli/fisiologia , Humanos , Staphylococcus/fisiologia , Propriedades de Superfície
7.
Biointerphases ; 11(3): 031002, 2016 09 11.
Artigo em Inglês | MEDLINE | ID: mdl-27400747

RESUMO

The most prominent character of a new type of antibacterial urological catheters is the zebra-stripe pattern of a silver film, which is plated electroless on their interior wall and capped by a very thin semipermeable layer of parylene. This design effectively controls the release rate of Ag(+) ions in artificial urine, which has been measured as function of time with optical emission spectroscopy. By evaluating the minimum inhibitory concentration against certain strains of bacteria with solutions of AgNO3 of known concentration with the method of optical density and applying this analysis to the silver-eluting catheters, it was shown that this moderation prolongs the period of their application significantly. But to act as antibacterial agent in chlorine-containing solutions, as in urine, the presence of urea is required to avoid precipitation of AgCl and to meet or even exceed the minimum inhibitory concentration of Ag(+). The quality of the silver depot layer was further determined by the deposition rate and its morphology, which revealed that the film consisted of grains with a mean size of 150 nm.


Assuntos
Anti-Infecciosos/farmacocinética , Íons/farmacocinética , Nanopartículas/química , Prata/farmacocinética , Cateteres Urinários , Bactérias/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Análise Espectral
8.
Dtsch Med Wochenschr ; 140(19): 1462-4, 2015 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-26402185

RESUMO

HISTORY AND CLINICAL FINDINGS: We report the case of a 60-year-old man with localized erythema and edema, caused by an implanted cardioverter defibrillator (ICD). EXAMINATION: An infection could be excluded by clinical examination, para clinical parameters and clinical chemistry. The histologic examination was indicative for hypersensitivity reaction. Patch test was negative but nickel sensitization was seen by lymphocyte transformation test and nickel could be measured in the pacemaker eluate. TREATMENT AND COURSE: Based on the synopsis of negative patch testing, the hypersensitivity resembling histology and the corresponding in vitro analysis, the assumed cause for the dermatitis is a contact allergy to nickel as pacemaker component. After explantation, complete restitution of the skin could be observed. CONCLUSIONS: Unusual skin reactions in patients with cardiac pacemakers are mostly referred to as "Pacemaker dermatitis". There are various potential causes: first, an infection needs to be excluded. Then, the possibility of both "pressure damage" caused by the pacemaker and the mostly symptom free "pacemaker erythema with telangiectasia" - synonym "post implantation erythema" - needs to be considered. When suspecting an incompatibility of the implant, further allergologic testing is required. Often, the removal of the pacemaker is inevitable.


Assuntos
Desfibriladores Implantáveis/efeitos adversos , Edema , Eritema , Marca-Passo Artificial/efeitos adversos , Remoção de Dispositivo , Edema/etiologia , Edema/patologia , Eritema/etiologia , Eritema/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Níquel/efeitos adversos , Pele/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA